ERBB receptors in developing, dysplastic and malignant oral epithelia

J Rautava1, K J Jee, P J Miettinen

  • 1Department of Oral and Maxillofacial Surgery, Institute of Dentistry, University of Turku, Lemminkäisenkatu 2, Fin-20520, Turku, Finland. jaapoh@utu.fi <jaapoh@utu.fi>

Oral Oncology
|July 3, 2007
PubMed

Insights

This study investigated all four ERBB receptors in oral carcinogenesis. Increased epidermal growth factor receptor (EGFR) and ERBB4 nuclear staining were observed in oral dysplasias and squamous cell carcinomas (OSCCs).

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Oral squamous cell carcinomas (OSCCs) often overexpress epidermal growth factor receptor (EGFR).
  • The role of the entire ERBB receptor system in oral carcinogenesis is not fully understood.
  • ERBB receptors (EGFR, ERBB2, ERBB3, ERBB4) are crucial in cell growth and differentiation.

Purpose of the Study:

  • To investigate the expression and localization of all four ERBB receptors (EGFR, ERBB2-4) in normal, dysplastic, and malignant oral epithelia.
  • To correlate ERBB receptor expression with oral carcinogenesis.
  • To explore the potential clinical implications of ERBB receptor alterations in OSCC.

Main Methods:

  • Immunohistochemistry was used to study ERBB receptor expression in developing, normal, dysplastic, and OSCC tissues (n=58).
  • Reverse transcription-polymerase chain reaction (RT-PCR) was performed on 13 OSCC samples to assess ERBB receptor mRNA levels.
  • Quantitative analysis of receptor immunoreactivity and localization (cytoplasmic vs. nuclear) was conducted.

Main Results:

  • All four ERBB receptors were detected in developing and mature oral epithelium.
  • Increased epidermal growth factor receptor (EGFR) immunoreactivity was found in 61% of dysplasias and 54% of OSCCs.
  • Elevated ERBB4 nuclear staining was observed in 30% of dysplasias and 26% of OSCCs, suggesting potential roles in cancer progression.

Conclusions:

  • ERBB receptor expression profiles are distinct in different stages of oral carcinogenesis.
  • Increased nuclear translocation of ERBB4 may influence gene transcription and contribute to OSCC progression.
  • Understanding ERBB receptor dynamics offers potential therapeutic targets, especially with emerging EGFR inhibitors in oncology.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cellular Adaptation IV: Dysplasia and Metaplasia01:24

Cellular Adaptation IV: Dysplasia and Metaplasia

DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...